MOLLY GRASSMAN: Open Payments
NPI 1275807422 · FERNANDINA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,642 in 107 payments from 33 companies in 2025. Trend: 2023 $2,396 · 2024 $2,767 · 2025 $2,642
Food & beverage: $2,343Long term medical supply or device loan: $299
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $452 |
| AstraZeneca Pharmaceuticals LP | 14 | $301 |
| Janssen Biotech, Inc. | 13 | $262 |
| GlaxoSmithKline, LLC. | 11 | $201 |
| Incyte Corporation | 8 | $164 |
| BeOne Medicines USA, Inc. | 4 | $114 |
| PFIZER INC. | 6 | $111 |
| ABBVIE INC. | 4 | $104 |
| Daiichi Sankyo Inc. | 4 | $99 |
| Merck Sharp & Dohme LLC | 3 | $77 |
Products named: KISQALI, OJJAARA, JAKAFI, Enhertu, RYBREVANT, DARZALEX, REBLOZYL, EPKINLY.
Industry payments across FL — which companies pay providers there.
